What it means if ‘DNA is not destiny’

Geneticist David Sinclair says aging is a disease and it is preventable and treatable. He told the Fiduciary Investors Symposium that research demonstrates we can slow down or even reverse the aging process. It sounds like good news, but the consequences for society and the investment community are profound. 

Investors reflect on whether active managers can escape the Magnificent 7

Active managers has been under stress for several years due to lukewarm performance commonly attributed to the rise and rise of large cap technology stocks and passive investing. However, investors at the Top1000funds.com Fiduciary Investors Symposium concluded that the root cause of that stress might be more complicated.

Path to net zero requires honest dialogue about sustainable investing

Leading institutional investors at the Fiduciary Investors Symposium at Harvard said the industry could benefit from having a franker conversation about sustainable investments, both in terms of what climate goals are achievable on the path to net zero and what is behind the pushback on ESG funds.  

TPA: Unlocking alpha through enhanced liquidity management

Stronger liquidity management through a total portfolio approach (TPA) can do more than manage real-time risk exposures – it can also help generate alpha, according to panellists at the Fiduciary Investors Symposium at Harvard University.